Life Scientist > Health & Medical

Prana chief wins award

17 March, 2003 by Graeme O'Neill

The American Academy of Neurology has given its 2003 Potamkin Award for research into Alzheimer's disease to Dr Ashley Bush, co-founder of Melbourne biotechnology company Prana Biotechnology (ASX: PBT).


Melbourne scores $10 million Diabetes Vaccine Centre

14 March, 2003 by Jeremy Torr

Melbourne has been chosen as the site for the world's first Diabetes Vaccine Development Centre, a joint initiative of the National Health and Medical Research Council and the Juvenile Diabetes Research Foundation International.


Domantis signs deal with ImClone

11 March, 2003 by Graeme O'Neill

US anti-cancer therapeutics company ImClone Systems has signed an agreement with UK antibody engineering company Domantis, to use Domantis' proprietary domain-antibody technology to develop new therapeutics.


Remicade royalty refusal beggars analysis

04 March, 2003 by Graeme O'Neill

US biomedical company Centocor continues to puzzle analysts and investors alike with its refusal to pay royalties on its market-leading rheumatoid arthritis therapy Remicade to small Sydney biotechnology company Peptech.


CK Life, Swinburne team to trial ancient remedy as potential AIDS vaccine

03 March, 2003 by David Binning

CK Life Sciences, the biotech child of Asian business tycoon Li Ka Shing, will this month start an Australian trial of an AIDS vaccine drawn from ancient Chinese herbal remedies after inking a $600,000 deal with the Swinburne University Graduate School of Integrative Medicine.


ErbB2 research may give key to cancer growth

28 February, 2003 by Melissa Trudinger

Researchers at the CRC for Cellular Growth Factors have determined the structure of ErbB2, providing an important clue in how the molecule may contribute to the uncontrolled growth of cancer cells.


Bionomics, Florey in epilepsy collaboration

26 February, 2003 by Graeme O'Neill

Adelaide biomed company Bionomics (ASX: BNO) has established a strategic research collaboration with the Howard Florey Institute of Experimental Physiology and Medicine that it hopes will speed its development of new drugs for epilepsy and other brain disorders.


HIV vaccine research landscape 'not all doom and gloom'

25 February, 2003 by Graeme O'Neill

New approaches mean there is still hope for an effective HIV vaccine, Australian researchers have said in the wake of today's release of disappointing AIDS vaccine results by US company VaxGen.


WEHI scientist wins Eppendorf research award

21 February, 2003 by Melissa Trudinger

Hamish Scott, of Melbourne's Walter and Eliza Hall Institute of Medical Research, was presented with the Eppendorf Award for Young Australian Researchers at this week's 24th Lorne Genome Conference.


Garvan celebrates 40 years

18 February, 2003 by Iain Scott

Sydney's Garvan Institute of Medical Research yesterday threw a party to celebrate its 40th birthday.


NHMRC guidelines recommend embryo access freeze

14 February, 2003 by Pete Young

A freeze on access by researchers to any human embryo not in storage for at least one year is among proposed official guidelines on the use of embryonic stem cells released this week by the National Health and Medical Research Council (NHMRC).


Takeover bid made for Sirtex

12 February, 2003 by Iain Scott

US company Cephalon has made a $AUD271 million takeover offer for Sydney-based cancer treatment company Sirtex Medical.


Allergan deal paying off for Peplin

11 February, 2003 by Pete Young

The first fruits of anti-cancer drug developer Peplin Biotech's landmark licensing deal with US pharmaceutical company Allergan have surfaced in the form of a 240 per cent surge in Peplin's first-half revenues.


Malaria vaccine at least eight years away, conference told

10 February, 2003 by Graeme O'Neill

Veteran Melbourne malaria researcher Prof Robin Anders believes a malaria vaccine is still at least eight to 15 years away -- but he is optimistic that a vaccine is feasible, and will be effective, despite the phenomenal capacity of the parasite, Plasmodium falciparum, to take evasive action against drugs and vaccines.


New cancer genomics centre opens at Peter Mac

04 February, 2003 by Melissa Trudinger

The new Ian Potter Foundation Centre for Cancer Genomics and Predictive Medicine was opened today at the Peter MacCallum Cancer Institute by Victorian Innovation Minister John Brumby.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd